What is the current stock price of Biostage, Inc. (BSTG)?

As of the latest market data, Biostage, Inc. (BSTG) is trading at $4.03. The stock has seen a gain of 0.75% today.

Does Biostage, Inc. (BSTG) pay a dividend?

Based on current data, Biostage, Inc. does not have a confirmed active dividend policy.

What is the market cap of Biostage, Inc.?

The current market capitalization of Biostage, Inc. (BSTG) is approximately unavailable.

BSTG

Biostage, Inc.·Healthcare

4.03

0.750%(+0.03)

Market Closed

Last Updated: — ET

52W L: $3.6552W H: $9.00

BSTG NEWS

defenseworld.net

6d ago

Financial Analysis: Biostage (OTCMKTS:BSTG) and T2 Biosystems (NASDAQ:TTOO)

T2 Biosystems (NASDAQ: TTOO - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings. Earnings and Valuation This table compares T2 Biosystems

Company Profile

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2013-10-21

Beta

-0.97

Websitebiostage.com↗